{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:05:23Z","timestamp":1794848723595,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008678","name":"Universit\u00e4t Leipzig","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008678","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Macrophage efferocytosis, essential for the resolution of inflammation and plaque stability in atherosclerosis, is impaired in diabetes. Thrombomodulin (TM) and endothelial protein C receptor (EPCR), key mediators of protein C activation (PC), have vasculoprotective and anti-inflammatory roles, yet their involvement in macrophage efferocytosis in diabetes-induced atherosclerosis remains unclear. Here, we demonstrate that expression of EPCR was reduced in atherosclerotic lesions of diabetic patients compared to non-diabetic controls. In parallel, efferocytosis was impaired in atherosclerotic lesions and in monocytes derived macrophages of diabetic patients. In vitro, treatment with activated PC (aPC) or its cytoprotective selective variant (3K3A-aPC) restored high glucose-impaired macrophage efferocytosis. Mechanistic studies revealed that aPC restored efferocytosis through Arginase-1 and modulation of Rac1-ATF6 signaling. Additionally, macrophage protease-activated receptor 1 (PAR1) was identified as the key receptor mediating aPC\u2019s effects on efferocytosis. Mimicking biased PAR-1 signaling via parmodulin-2 reverses glucose impaired efferocytosis. In vivo, aPC treatment of diabetic ApoE\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice increased MerTK expression in atherosclerotic lesions. aPC\u2019s vasculoprotective effects, including the reduction of plaque size, were abrogated upon MerTK inhibition using morpholinos, underscoring the pivotal role of MerTK in mediating aPC\u2019s atheroprotective actions. These findings suggest that impaired TM-PAR1-aPC signaling contributes to defective macrophage efferocytosis in diabetes-associated atherosclerosis and that aPC-based therapies may offer a novel strategy to enhance macrophage function and prevent diabetes induced atherosclerosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12933-025-02965-5","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:04:36Z","timestamp":1760360676000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Activated protein C ameliorates diabetes-induced atherosclerosis by sustaining macrophage efferocytosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Saira","family":"Ambreen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikal","family":"Shamkeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elwakiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asad","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhir","family":"Halloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"Isermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurrum","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"2965_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature. 2021;592:524\u201333. https:\/\/doi.org\/10.1038\/s41586-021-03392-8.","journal-title":"Nature"},{"key":"2965_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/CIRCULATIONAHA.122.061983","volume":"147","author":"C Gyldenkerne","year":"2023","unstructured":"Gyldenkerne C, Maeng M, Kjoller-Hansen L, Maehara A, Zhou Z, Ben-Yehuda O, et al. Coronary artery lesion lipid content and plaque burden in diabetic and nondiabetic patients: PROSPECT II. Circulation. 2023;147:469\u201381. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.061983.","journal-title":"Circulation"},{"key":"2965_CR3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1111600109","volume":"109","author":"JE Kanter","year":"2012","unstructured":"Kanter JE, Kramer F, Barnhart S, Averill MM, Vivekanandan-Giri A, Vickery T, et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc Natl Acad Sci U S A. 2012;109:E715\u2013724. https:\/\/doi.org\/10.1073\/pnas.1111600109.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2965_CR4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/CIRCRESAHA.121.320060","volume":"130","author":"Y Matsuura","year":"2022","unstructured":"Matsuura Y, Shimizu-Albergine M, Barnhart S, Kramer F, Hsu CC, Kothari V, et al. Diabetes suppresses glucose uptake and glycolysis in macrophages. Circ Res. 2022;130:779\u201381. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.320060.","journal-title":"Circ Res"},{"key":"2965_CR5","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1161\/CIRCRESAHA.119.315939","volume":"126","author":"I Tabas","year":"2020","unstructured":"Tabas I, Bornfeldt KE. Intracellular and intercellular aspects of macrophage immunometabolism in atherosclerosis. Circ Res. 2020;126:1209\u201327. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315939.","journal-title":"Circ Res"},{"issue":"518\u2013533","key":"2965_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.01.001","volume":"31","author":"A Yurdagul Jr","year":"2020","unstructured":"Yurdagul A Jr, Subramanian M, Wang X, Crown SB, Ilkayeva OR, Darville L, et al. Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab. 2020;31(518\u2013533):e510. https:\/\/doi.org\/10.1016\/j.cmet.2020.01.001.","journal-title":"Cell Metab"},{"key":"2965_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/d41573-022-00097-z","volume":"21","author":"S Crunkhorn","year":"2022","unstructured":"Crunkhorn S. Promoting efferocytosis heals diabetic wounds. Nat Rev Drug Discov. 2022;21:491. https:\/\/doi.org\/10.1038\/d41573-022-00097-z.","journal-title":"Nat Rev Drug Discov"},{"key":"2965_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02463-y","volume":"22","author":"S Qiu","year":"2024","unstructured":"Qiu S, Liu J, Chen J, Li Y, Bu T, Li Z, et al. Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE(-\/-) mice. J Nanobiotechnology. 2024;22:178. https:\/\/doi.org\/10.1186\/s12951-024-02463-y.","journal-title":"J Nanobiotechnology"},{"key":"2965_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI145275","author":"C Kasikara","year":"2021","unstructured":"Kasikara C, Schilperoort M, Gerlach B, Xue C, Wang X, Zheng Z, et al. Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI145275.","journal-title":"J Clin Invest"},{"key":"2965_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1172\/JCI90520","volume":"127","author":"B Cai","year":"2017","unstructured":"Cai B, Thorp EB, Doran AC, Sansbury BE, Daemen MJ, Dorweiler B, et al. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J Clin Invest. 2017;127:564\u20138. https:\/\/doi.org\/10.1172\/JCI90520.","journal-title":"J Clin Invest"},{"key":"2965_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s42003-018-0108-5","volume":"1","author":"K Shahzad","year":"2018","unstructured":"Shahzad K, Gadi I, Nazir S, Al-Dabet MM, Kohli S, Bock F, et al. Activated protein C reverses epigenetically sustained p66(Shc) expression in plaque-associated macrophages in diabetes. Commun Biol. 2018;1:104. https:\/\/doi.org\/10.1038\/s42003-018-0108-5.","journal-title":"Commun Biol"},{"key":"2965_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/nu14142786","author":"S Fatima","year":"2022","unstructured":"Fatima S, Ambreen S, Mathew A, Elwakiel A, Gupta A, Singh K, et al. ER-stress and senescence coordinately promote endothelial barrier dysfunction in diabetes-induced atherosclerosis. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14142786.","journal-title":"Nutrients"},{"key":"2965_CR13","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/nm1667","volume":"13","author":"B Isermann","year":"2007","unstructured":"Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med. 2007;13:1349\u201358. https:\/\/doi.org\/10.1038\/nm1667.","journal-title":"Nat Med"},{"key":"2965_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0002-9440(10)61753-1","volume":"159","author":"ZG Laszik","year":"2001","unstructured":"Laszik ZG, Zhou XJ, Ferrell GL, Silva FG, Esmon CT. Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. Am J Pathol. 2001;159:797\u2013802. https:\/\/doi.org\/10.1016\/S0002-9440(10)61753-1.","journal-title":"Am J Pathol"},{"key":"2965_CR15","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.109.849539","volume":"120","author":"S Seehaus","year":"2009","unstructured":"Seehaus S, Shahzad K, Kashif M, Vinnikov IA, Schiller M, Wang H, et al. Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability. Circulation. 2009;120:774\u201384. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.849539.","journal-title":"Circulation"},{"key":"2965_CR16","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1161\/ATVBAHA.124.320800","volume":"44","author":"S Karnewar","year":"2024","unstructured":"Karnewar S, Karnewar V, Deaton RA, Shankman LS, Benavente ED, Williams CM, et al. IL-1\u03b2 inhibition partially negates the beneficial effects of diet-induced atherosclerosis regression in mice. Arterioscler Thromb Vasc Biol. 2024;44:1379\u201392. https:\/\/doi.org\/10.1161\/ATVBAHA.124.320800.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2965_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2011.05.041","volume":"219","author":"K Shahzad","year":"2011","unstructured":"Shahzad K, Thati M, Wang H, Kashif M, Wolter J, Ranjan S, et al. Minocycline reduces plaque size in diet induced atherosclerosis via p27(Kip1). Atherosclerosis. 2011;219:74\u201383. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.05.041.","journal-title":"Atherosclerosis"},{"key":"2965_CR18","doi-asserted-by":"publisher","DOI":"10.3791\/1488","author":"A Ray","year":"2010","unstructured":"Ray A, Dittel BN. Isolation of mouse peritoneal cavity cells. J Vis Exp. 2010. https:\/\/doi.org\/10.3791\/1488.","journal-title":"J Vis Exp"},{"key":"2965_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.101004","volume":"2","author":"T Nguyen","year":"2021","unstructured":"Nguyen T, Du J, Li YC. A protocol for macrophage depletion and reconstitution in a mouse model of sepsis. STAR Protoc. 2021;2:101004. https:\/\/doi.org\/10.1016\/j.xpro.2021.101004.","journal-title":"STAR Protoc"},{"key":"2965_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41569-024-01037-7","volume":"21","author":"SS Adkar","year":"2024","unstructured":"Adkar SS, Leeper NJ. Efferocytosis in atherosclerosis. Nat Rev Cardiol. 2024;21:762\u201379. https:\/\/doi.org\/10.1038\/s41569-024-01037-7.","journal-title":"Nat Rev Cardiol"},{"key":"2965_CR21","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131355","author":"W Cai","year":"2019","unstructured":"Cai W, Dai X, Chen J, Zhao J, Xu M, Zhang L, et al. STAT6\/Arg1 promotes microglia\/macrophage efferocytosis and inflammation resolution in stroke mice. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.131355.","journal-title":"JCI Insight"},{"key":"2965_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1476-5381.2008.00036.x","volume":"156","author":"NN Huynh","year":"2009","unstructured":"Huynh NN, Harris EE, Chin-Dusting JF, Andrews KL. The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries. Br J Pharmacol. 2009;156:84\u201393. https:\/\/doi.org\/10.1111\/j.1476-5381.2008.00036.x.","journal-title":"Br J Pharmacol"},{"key":"2965_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cmet.2020.02.005","volume":"31","author":"DJ Puleston","year":"2020","unstructured":"Puleston DJ, Pearce EL. Appetite for arginine: metabolic control of macrophage hunger. Cell Metab. 2020;31:441\u20132. https:\/\/doi.org\/10.1016\/j.cmet.2020.02.005.","journal-title":"Cell Metab"},{"key":"2965_CR24","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1161\/ATVBAHA.120.315622","volume":"41","author":"A Yurdagul","year":"2021","unstructured":"Yurdagul A, Kong N, Gerlach BD, Wang X, Ampomah P, Kuriakose G, et al. ODC (Ornithine Decarboxylase)-dependent putrescine synthesis maintains MerTK (MER Tyrosine-Protein Kinase) expression to drive resolution. Arterioscler Thromb Vasc Biol. 2021;41:e144\u201359. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315622.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2965_CR25","doi-asserted-by":"publisher","first-page":"E1372","DOI":"10.1073\/pnas.1112482108","volume":"108","author":"UJ Soh","year":"2011","unstructured":"Soh UJ, Trejo J. Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through \u03b2-arrestin and dishevelled-2 scaffolds. Proc Natl Acad Sci U S A. 2011;108:E1372-1380. https:\/\/doi.org\/10.1073\/pnas.1112482108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2965_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1160\/TH08-09-0568","volume":"101","author":"JS Bae","year":"2009","unstructured":"Bae JS, Rezaie AR. Thrombin inhibits nuclear factor kappaB and RhoA pathways in cytokine-stimulated vascular endothelial cells when EPCR is occupied by protein C. Thromb Haemost. 2009;101:513\u201320.","journal-title":"Thromb Haemost"},{"key":"2965_CR27","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/j.1538-7836.2010.03812.x","volume":"8","author":"JS Bae","year":"2010","unstructured":"Bae JS, Rezaie AR. Thrombin upregulates the angiopoietin-Tie2 axis: endothelial protein C receptor occupancy prevents the thrombin mobilization of angiopoietin 2 and P-selectin from Weibel-Palade bodies. J Thromb Haemost. 2010;8:1107\u201315. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03812.x.","journal-title":"J Thromb Haemost"},{"key":"2965_CR28","doi-asserted-by":"publisher","first-page":"6496","DOI":"10.1038\/ncomms7496","volume":"6","author":"T Madhusudhan","year":"2015","unstructured":"Madhusudhan T, Wang H, Dong W, Ghosh S, Bock F, Thangapandi VR, et al. Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy. Nat Commun. 2015;6:6496. https:\/\/doi.org\/10.1038\/ncomms7496.","journal-title":"Nat Commun"},{"key":"2965_CR29","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1182\/blood-2017-05-782102","volume":"130","author":"S Nazir","year":"2017","unstructured":"Nazir S, Gadi I, Al-Dabet MM, Elwakiel A, Kohli S, Ghosh S, et al. Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition. Blood. 2017;130:2664\u201377. https:\/\/doi.org\/10.1182\/blood-2017-05-782102.","journal-title":"Blood"},{"key":"2965_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/MOH.0000000000000473","volume":"26","author":"K Shahzad","year":"2019","unstructured":"Shahzad K, Kohli S, Al-Dabet MM, Isermann B. Cell biology of activated protein C. Curr Opin Hematol. 2019;26:41\u201350. https:\/\/doi.org\/10.1097\/MOH.0000000000000473.","journal-title":"Curr Opin Hematol"},{"key":"2965_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/nu14101991","author":"S Ambreen","year":"2022","unstructured":"Ambreen S, Fatima S, Elwakiel A, Rana R, Singh K, Gupta A, et al. Hypercoagulability impairs plaque stability in diabetes-induced atherosclerosis. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14101991.","journal-title":"Nutrients"},{"key":"2965_CR32","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1464-5491.2007.02289.x","volume":"24","author":"K Matsumoto","year":"2007","unstructured":"Matsumoto K, Yano Y, Gabazza EC, Araki R, Bruno NE, Suematsu M, et al. Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients. Diabet Med. 2007;24:1322\u20138. https:\/\/doi.org\/10.1111\/j.1464-5491.2007.02289.x.","journal-title":"Diabet Med"},{"key":"2965_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174603","volume":"12","author":"SY Kim","year":"2017","unstructured":"Kim SY, Kim S, Bae DJ, Park SY, Lee GY, Park GM, et al. Coordinated balance of Rac1 and RhoA plays key roles in determining phagocytic appetite. PLoS ONE. 2017;12:e0174603. https:\/\/doi.org\/10.1371\/journal.pone.0174603.","journal-title":"PLoS ONE"},{"key":"2965_CR34","doi-asserted-by":"publisher","first-page":"49911","DOI":"10.1074\/jbc.M306079200","volume":"278","author":"AC Tosello-Trampont","year":"2003","unstructured":"Tosello-Trampont AC, Nakada-Tsukui K, Ravichandran KS. Engulfment of apoptotic cells is negatively regulated by Rho-mediated signaling. J Biol Chem. 2003;278:49911\u20139. https:\/\/doi.org\/10.1074\/jbc.M306079200.","journal-title":"J Biol Chem"},{"key":"2965_CR35","doi-asserted-by":"publisher","first-page":"9198","DOI":"10.1073\/pnas.0803677105","volume":"105","author":"M Nakaya","year":"2008","unstructured":"Nakaya M, Kitano M, Matsuda M, Nagata S. Spatiotemporal activation of Rac1 for engulfment of apoptotic cells. Proc Natl Acad Sci U S A. 2008;105:9198\u2013203. https:\/\/doi.org\/10.1073\/pnas.0803677105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2965_CR36","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1172\/JCI94735","volume":"127","author":"AC Doran","year":"2017","unstructured":"Doran AC, Ozcan L, Cai B, Zheng Z, Fredman G, Rymond CC, et al. CAMKII\u03b3 suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis. J Clin Invest. 2017;127:4075\u201389. https:\/\/doi.org\/10.1172\/JCI94735.","journal-title":"J Clin Invest"},{"key":"2965_CR37","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1182\/blood-2017-02-767921","volume":"130","author":"T Madhusudhan","year":"2017","unstructured":"Madhusudhan T, Wang H, Ghosh S, Dong W, Kumar V, Al-Dabet MM, et al. Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function. Blood. 2017;130:1445\u201355. https:\/\/doi.org\/10.1182\/blood-2017-02-767921.","journal-title":"Blood"},{"key":"2965_CR38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tins.2011.01.005","volume":"34","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV, Griffin JH. Cytoprotective protein C pathways and implications for stroke and neurological disorders. Trends Neurosci. 2011;34:198\u2013209. https:\/\/doi.org\/10.1016\/j.tins.2011.01.005.","journal-title":"Trends Neurosci"},{"key":"2965_CR39","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1182\/blood.2023019775","volume":"141","author":"G Kunze","year":"2023","unstructured":"Kunze G, Isermann B. Targeting biased signaling by PAR1: function and molecular mechanism of parmodulins. Blood. 2023;141:2675\u201384. https:\/\/doi.org\/10.1182\/blood.2023019775.","journal-title":"Blood"},{"key":"2965_CR40","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1182\/blood-2011-07-365973","volume":"119","author":"T Madhusudhan","year":"2012","unstructured":"Madhusudhan T, Wang H, Straub BK, Grone E, Zhou Q, Shahzad K, et al. Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood. 2012;119:874\u201383. https:\/\/doi.org\/10.1182\/blood-2011-07-365973.","journal-title":"Blood"},{"key":"2965_CR41","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1182\/blood-2013-03-488957","volume":"122","author":"L Burnier","year":"2013","unstructured":"Burnier L, Mosnier LO. Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3. Blood. 2013;122:807\u201316. https:\/\/doi.org\/10.1182\/blood-2013-03-488957.","journal-title":"Blood"},{"key":"2965_CR42","doi-asserted-by":"publisher","first-page":"E982","DOI":"10.1073\/pnas.1718600115","volume":"115","author":"K De Ceunynck","year":"2018","unstructured":"De Ceunynck K, Peters CG, Jain A, Higgins SJ, Aisiku O, Fitch-Tewfik JL, et al. PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury. Proc Natl Acad Sci U S A. 2018;115:E982\u201391. https:\/\/doi.org\/10.1073\/pnas.1718600115.","journal-title":"Proc Natl Acad Sci U S A"}],"updated-by":[{"DOI":"10.1186\/s12933-025-03058-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000}}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02965-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02965-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02965-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:22:22Z","timestamp":1768818142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-025-02965-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2965"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02965-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12933-025-03058-z","URL":"https:\/\/doi.org\/10.1186\/s12933-025-03058-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"396"}}